Gallery
Picture 1
Mckesson stock price "McKesson stock price" benefits from
New with box
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
"McKesson stock price" benefits from structural healthcare growth and rising demand for biologics. Analysts note long-term tailwinds from federal healthcare programs increasing patient access to specialty drugs. If you are a Registered Investment Advisor (RIA) or are a serious investor, take your investing to the next level and follow our free weekly MoneyFlows insights . Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial. As of today, "McKesson stock price" is slightly up by 0.8%, outperforming the broader S&P 500 healthcare sector. Market sentiment is supported by higher prescription volumes and robust oncology drug distribution services. Analysts forecast moderate upside potential if inflation pressures ease.